Back to Market Feed

Product Information

METHYLDOPA 250 MG TABLET is a generic product labeled by Rising Pharma Holdings Inc., priced at $7.4999 per EA under NDC 64980057101. Its NADAC has been published 47 times since Aug 27, 2025.

FDA first approved this application on Apr 18, 1985.

METHYLDOPA 250 MG TABLET

methyldopa
$7.4999per EA

Strength

250 mg/1

NDC

64980057101

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

8/27/2025

Active Ingredients

METHYLDOPA

Approval Type

Generic (ANDA)

FDA Application

ANDA070076

FDA Approved

4/18/1985

On Market Since

4/4/2025

Pharmacological Classes

Adrenergic alpha2-Agonists
Central alpha-2 Adrenergic Agonist

Price Statistics

The NADAC for METHYLDOPA 250 MG TABLET has been published 47 times since Aug 27, 2025, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.

Current price$7.4999 per EA
All-time high$7.4999 (Jul 15, 2026)
All-time low$7.4999 (Aug 27, 2025)
52-week high$7.4999
52-week low$7.4999
Median price$7.4999
Average price$7.4999
Largest weekly change0.0% (Sep 3, 2025)
Weeks tracked47
Tracking sinceAug 27, 2025

Price History

1W

N/A

1M

N/A

3M

0.0%

6M

0.0%

1Y

N/A

3Y

N/A

5Y

N/A

All

0.0%

Last surveyed Jul 15, 2026 — this NDC no longer appears in the current weekly NADAC file.

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the methyldopa market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Related Drugs

Same classification

CLONIDINE HCL 0.1 MG TABLET
Generic
00228212710•Actavis Pharma, Inc.
$0.0245
per EA
CLONIDINE HCL 0.1 MG TABLET
Generic
00228212750•Actavis Pharma, Inc.
$0.0245
per EA
CLONIDINE HCL 0.1 MG TABLET
Generic
00904744261•Major Pharmaceuticals
$0.0245
per EA
CLONIDINE HCL 0.1 MG TABLET
Generic
29300046801•Unichem Pharmaceuticals (USA) Inc.
$0.0245
per EA
CLONIDINE HCL 0.1 MG TABLET
Generic
29300046805•Unichem Pharmaceuticals (USA) Inc.
$0.0245
per EA
CLONIDINE HCL 0.1 MG TABLET
Generic
29300046810•Unichem Pharmaceuticals (USA) Inc.
$0.0245
per EA
CLONIDINE HCL 0.1 MG TABLET
Generic
43547056510•Solco Healthcare US LLC
$0.0245
per EA
CLONIDINE HCL 0.1 MG TABLET
Generic
43547056511•Solco Healthcare US LLC
$0.0245
per EA
CLONIDINE HCL 0.1 MG TABLET
Generic
50268019215•AvPAK
$0.0245
per EA
CLONIDINE HCL 0.1 MG TABLET
Generic
52817018000•TruPharma LLC
$0.0245
per EA

Frequently asked questions

What is the NADAC price of METHYLDOPA 250 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for METHYLDOPA 250 MG TABLET, manufactured by Rising Pharma Holdings Inc., is $7.4999 per EA (NDC 64980057101), effective Jul 15, 2026.

How has the price of METHYLDOPA 250 MG TABLET changed over time?

Over the history we have for it, the NADAC for METHYLDOPA 250 MG TABLET has held within roughly two percent of its current level. It has been tracked across 47 weekly CMS publications since Aug 27, 2025.

What are the highest and lowest recorded NADAC prices for METHYLDOPA 250 MG TABLET?

Since Aug 27, 2025, the NADAC for METHYLDOPA 250 MG TABLET has ranged from a low of $7.4999 (Aug 27, 2025) to a high of $7.4999 (Jul 15, 2026), with a median of $7.4999 per EA.

Are there cheaper alternatives to METHYLDOPA 250 MG TABLET?

No other NADAC-published product currently shares the active ingredient and strength of METHYLDOPA 250 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures METHYLDOPA 250 MG TABLET?

METHYLDOPA 250 MG TABLET (NDC 64980057101) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.